Reports and Data

Molecular Diagnostics Market Size, Competitors Strategy, Regional Analysis and Industry Growth by Forecast to 2026 : Abbott, Roche Diagnostics, QIAGEN

 

New York, NY -- (SBWIRE) -- 01/21/2021 -- According to the current analysis of Reports and Data, the global Molecular Diagnostics market was valued at USD 7.28 Billion in 2018 and is expected to reach USD 13.81 Billion by year 2026, at a CAGR of 8.2%. The increasing efficiency of clinical trials, growing incidence of infectious and neurological diseases, and technological advancements in molecular pathology are major driving factors being the growth of the market. The increasing government aid for research and establishment of advanced testing facilities is also supporting the growth of the market.

Get a Sample Report PDF with Detail TOC & List of Figures @ https://www.reportsanddata.com/sample-enquiry-form/945

Leading Players Profiled in the Report Include:

Abbott, Roche Diagnostics, QIAGEN, Danaher, Hologic, Becton, Siemens Healthcare GmbH, Bio-Rad Laboratories, Dickinson and Co., Cephei

The developing economies of India and China face some challenges in the form of the lack of a well-built procedural system for approvals, which hinders the growth of the molecular diagnostics market. Moreover, a shortage of skilled medical professionals is also limiting the growth of the market in many countries.

Further key findings from the report suggest-

The Veterinary Molecular Diagnostics market is witnessing a blooming growth as fungicidal therapies are being increasingly developed. Moreover, the development of specific assays and reagents has also contributed to the growth of the market.

Based on product and service type, the reagents and kits segment held the largest share in the market in base year 2018. The increasing ease of usage and a widening applicability of reagents and kits is boosting market growth.

Based on technology, the Polymerase Chain Reaction (PCR) segment held the largest share in the global Molecular Diagnostics market. The penetration of technological advancements in medical science along with the growing automation of PCR instruments contributes to this share.

in Situ Hybridization is also a high growth registering technology because of the rising number of cancer cases and the resultant need of early diagnosis. Ongoing research and greater targeted funding are pushing the growth of this technology forward.

By application, infectious diseases form the largest segment as they make the maximum usage of Molecular Diagnostics for diagnosis and therapeutic purposes. The incidence of infectious diseases has been increasing and government support is strong to eradicate their spread.

The oncology segment, by application, is expected to register the highest CAGR during the period of forecast. The colorectal cancer molecular diagnostics, in particular, has been registering an impressive rate of growth during the forecast period.

The instruments segment is expected to register a high CAGR during the forecast period. The demand for instruments is mainly driven by testing laboratories and clinics.

Based on end user, hospitals and academic laboratories hold the largest share in the Molecular Diagnostics market. A strong research-driven growth and increasing cases of disease, especially in the geriatric population, contribute to this share.

By region, North America is the most developed region due to an impressive growth in medical science and the presence of a highly skilled medical personnel. The high research funding also goes a long way in maintaining the fast pace of advancement in the field.

Get Attractive Discount @ https://www.reportsanddata.com/discount-enquiry-form/945

For the purpose of this report, Reports and Data has segmented the Molecular Diagnostics market on the basis of product and service, technology, application, end use, and region:

Product and Service (Revenue, USD Million; 2016–2026)

Reagents and Kits
Instruments
Services and Software

Technology (Revenue, USD Million; 2016–2026)

Polymerase Chain Reaction (PCR) 
Isothermal Nucleic Acid Amplification Technology (INAAT) 
DNA Sequencing & Next-Generation Sequencing (NGS) 
in Situ Hybridization 
DNA Microarray 
Other Technologies

Application (Revenue, USD Million; 2016–2026)

Infectious Diseases
Hepatitis
HIV
CT/NG
HAIS
HPV
Tuberculosis
Influenza
Other Infectious Diseases
Oncology
Breast Cancer
Colorectal Cancer
Lung Cancer
Prostate Cancer
Other Cancers
Genetic Tests
Others

End Use (Revenue, USD Million; 2016–2026)

Hospital and Academic Laboratories
Reference Laboratories
Others

Regional Outlook (Revenue in USD Million; 2016–2026)

North America
Europe
Asia Pacific
Middle East and Africa
Latin America

Browse Complete Report "Molecular Diagnostics Market" @ https://www.reportsanddata.com/report-detail/global-molecular-diagnostics-market

Table of contents

Chapter 1. Market Synopsis

    1.1. Market Definition

    1.2. Research Scope & Premise

    1.3. Methodology

    1.4. Market Estimation Technique

Chapter 2. Executive Summary

    2.1. Summary Snapshot, 2018 – 2026

Chapter 3. Indicative Metrics

    3.1. Increasing incidence of infectious diseases

    3.2. Extensive growth of medical science

    3.3. Growing application of personalized medication

Chapter 4. Molecular Diagnostics Segmentation & Impact Analysis

    4.1. Molecular Diagnostics Segmentation Analysis

    4.2. Molecular Diagnostics Market Value Chain Analysis, 2016-2026

    4.3. Regulatory framework

Continued…

Read More Reports:-

Surgical Sealants & Adhesives Market Key Players

Aerogel Market Demand

Bio Decontamination Market Competitive Landscape

Home Infusion Therapy Market Segments

Surgical Glue Market Overview

About Reports and Data                              

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.